Healthcare budgets around the world are under growing pressures, exacerbated by the COVID-19 pandemic, the military conflict in Ukraine, and subsequent economic, fiscal and debt crises. In these circumstances, it is more important than ever that governments institutionalise evidence-based priority setting processes, such as HTA to rigorously, systematically, and transparently allocate finite health resources based on evidence to maximise health benefit and support universal health coverage (UHC). Priority setting institutions that use HTA methods have an important role to play in supporting health systems to decide which health services and technologies to fund, to whom, and at what cost. However, since such institutions can divert resources away from other health priorities, it is important to understand the extent to which they are providing value for money. This evidence can help governments decide whether, and to what extent, to invest in HTA institutions.
